Clinical trial
High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood
NCT00180791 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Unknown status
Key facts
| NCT number | NCT00180791 |
|---|---|
| Title | High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood |
| Official title | Treatment Protocol for High-Risk PNET Brain Tumors in Children With Surgery, Sequential Chemotherapy, Conventional and High-Dose With Peripheral Blood Stem Cell Transplantation and Radiation Therapy |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Medulloblastoma, Brain Tumors, Neuroectodermal Tumors, Primitive |
| Intervention type | Drug |
| Interventions | Etoposide, carboplatin, melphalan, cisplatin, thiotepa |
| Enrollment | 71 |
| Start date | Jul 1, 2002 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 18, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: